在德国军用飞机机组人员中治疗心房动
Norbert Guettler1,2, Stefan Sammito3,4
1German Air Force Centre of Aerospace Medicine, Flughafenstrasse 1, Cologne, 51147, Germany. guettlern@aol.com.
概括
德国军用机组人员的心房动 (AF) 是可以控制的,大多数飞行员都恢复了飞行任务. 仔细的个案评估确保了要求高的航空角色的安全性.
科学领域:
- 航空航天医学 航空航天医学
- 心脏病学 心脏病学
- 职业健康 职业健康 职业健康
背景情况:
- 心房动 (AF) 是一种常见的心律失常症,也是飞行员失去飞行特权的常见原因.
- 军用机组人员在独特的,高需求的环境中工作,需要专门的医疗考虑.
研究的目的:
- 分析德国军用飞行员中AF的临床和职业方面.
- 在这个高度精选的人口群体中确定AF的特定特征.
- 讨论AF管理策略,以可能恢复飞行任务.
主要方法:
- 德国空军航空航天医学中心 (GAFCAM) 数字记录的34年后期分析.
- 包括被诊断患有AF的飞行员和非飞行员机组人员.
- 根据当前的指导方针评估潜在的疾病,AF特征,临床发现和职业决策.
主要成果:
- 42名男性飞行员 (19名飞行员) 在1989年至2023年期间被诊断患有AF;平均年龄为47岁.
- 大多数AF发作是单一的 (23) 或有机的 (16),64%的发作自发终止.
- 在42名机组人员中,有36名机组人员恢复了飞行身份,通常有限制;6人被永久取消资格.
结论:
- 军用机组人员的AF管理需要采用整体方法,将临床指导与飞行环境考虑相结合.
- 航空医学决策必须是个性化的,基于法规,临床状况和工作要求.
- 这项研究强调了许多有AF的机组人员成功恢复飞行任务的潜力.
相关概念视频
01:26Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
01:25Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
01:25Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
01:25Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
01:21Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
01:26Flail Chest-II
206
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
206